ARCHIVES

New Drug Approvals Point To Greater Role Of Randomization In Cancer Clinical Trials. European Standards Will Demand More Rigor.

This article is from The Cancer Letter archive.

Vol. 32 No. 07 | February 24, 2006

Download PDF Visit The Full Archive

Related Articles

NCI-Approved CTEP Trials For the Month of November

November 30, 2012

Mayo Clinic’s NCI Designation Extended To Arizona, Florida Sites

July 26, 2002

Henry Kaplan Was One Of The Century’s Top Scientists, DeVita Says

March 23, 1984

More Radiation Increases Prostate Cancer Response

August 30, 2002

NCI Cooperative Group Clinical Trials Approved

October 29, 2010

Tests Find No Conclusive Evidence On Two Chemicals

September 21, 1979